Companies › RADX

RADIOPHARM THERANOSTICS LTD (RADX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001949257 · EDGAR filings · Updated 2026-07-28

RADIOPHARM THERANOSTICS LTD (RADX) has reported institutional ownership of 2.2%, with 7 institutional managers holding positions valued at $2.06M per the latest 13F reporting period.

Filings this week (6)

• 2026-07-28 — Foreign issuer report (6-K) filed
• 2026-07-28 — Foreign issuer report (6-K) filed
• 2026-07-27 — Foreign issuer report (6-K) filed
• 2026-07-27 — Prospectus supplement (424B5) filed
• 2026-07-24 — Foreign issuer report (6-K) filed
• 2026-07-23 — Prospectus supplement (424B5) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, RADIOPHARM THERANOSTICS LTD has 7 institutional holders and institutional ownership of 2.2%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Related companies

SYNERGY CHC CORP (SNYR) · VIVOS THERAPEUTICS INC (VVOS) · Reviva Pharmaceuticals Holdings Inc (RVPH) · PURETECH HEALTH PLC (PRTCY) · BIOFRONTERA INC (BFRI) · CRYO-CELL INTL INC (CCEL)